DexCom (NASDAQ:DXCM – Get Rating) had its price objective increased by UBS Group from $142.00 to $150.00 in a research note published on Friday morning, The Fly reports. Other analysts also recently issued reports about the company. Wolfe Research initiated coverage on DexCom in a research note on Thursday, January 26th. They set an outperform […]
Retirement Systems of Alabama lessened its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 5.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 123,743 shares of the medical device company’s stock after selling 6,652 shares during the period. Retirement Systems […]
DexCom, Inc. (NASDAQ:DXCM – Get Rating) hit a new 52-week high on Thursday following a stronger than expected earnings report. The stock traded as high as $126.44 and last traded at $121.69, with a volume of 325550 shares changing hands. The stock had previously closed at $124.93. The medical device company reported $0.17 earnings per […]
Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 6.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 29,625 shares of the medical device company’s stock after purchasing an additional […]
Bard Financial Services Inc. acquired a new stake in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 2,225 shares of the medical device company’s stock, valued at approximately $252,000. Other institutional investors […]